Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results

PURPOSE: Eribulin mesilate was approved for the treatment of patients with locally advanced or metastatic breast cancer (MBC), who had received at least two chemotherapeutic regimens, including anthracycline and taxane. On the other hand, the efficacy and safety information of eribulin in Korean pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Res Treat
Autors principals: Park, Yeon Hee, Kim, Tae Yong, Im, Young-Hyuck, Lee, Keun-Seok, Park, In Hae, Sohn, Joohyuk, Lee, Soo-Hyeon, Im, Seock-Ah, Kim, Jee Hyun, Kim, Se Hyun, Lee, Soo Jung, Koh, Su-Jin, Lee, Ki Hyeong, Choi, Yoon Ji, Cho, Eun Kyung, Lee, Suee, Kang, Seok Yun, Seo, Jae Hong, Kim, Sung-Bae, Jung, Kyung Hae
Format: Artigo
Idioma:Inglês
Publicat: Korean Cancer Association 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5398406/
https://ncbi.nlm.nih.gov/pubmed/27488876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.191
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars